Article
HBO1 Suppresses Anti-Tumor Immunity of CD8⁺ T Cells in Thyroid Cancer by Recruiting BRD4 to Regulate VTCN1 Expression
2026-03-25
Abstract excerpt
<title>Abstract</title> <p> Thyroid cancer is the most common endocrine malignancy. Although surgery remains the primary treatment, advanced disease frequently recurs or metastasizes, and subsequent therapies yield suboptimal outcomes. Immunotherapy holds promise, yet the underlying immune-evasion mechanisms remain incompletely understood. HBO1, a multifunctional acyltransferase, plays a significant role in tumo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de34b7a5-b291-5c0c-917e-599ae36f6aba
- DOI
- 10.21203/rs.3.rs-9138728/v1
